Digest Réseau Comment ça marche
Réseau
/
Sociétés
Bi
Non vérifié

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Ce que nous écrivons

BiotechnologieIndustrie pharmaceutiqueMédecine - DiversSantéScience

18 communiqués de presse

Voir tous les communiqués de presse
10/12/2025
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
Source
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Émetteur
Business Wire
1.00
0
10/12/2025
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
Source
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Émetteur
Business Wire
1.00
0
05/12/2025
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
Source
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Émetteur
Business Wire
1.00
0
05/12/2025
Science
Hygiène alimentaire
Médecine - Divers
Biotechnologie
Santé
Industrie pharmaceutique
Santé Publique
Oncologie
Marché du travail
Industrie
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
Source
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Émetteur
Business Wire
1.00
0
16/09/2025
Oncologie
Santé
Médecine - Divers
Science
Industrie pharmaceutique
Biotechnologie
Marché du travail
Industrie
Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single Antibody
Source
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Émetteur
Business Wire
1.00
0
16/09/2025
Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single Antibody
Source
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Émetteur
Business Wire
1.00
0
04/09/2025
Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
Source
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Émetteur
Business Wire
1.00
0
04/09/2025
Biocytogen Enters into Agreement with Merck, KGaA, Darmstadt, Germany to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
Source
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Émetteur
Business Wire
1.00
0
10/07/2025
Science
Biotechnologie
Industrie pharmaceutique
Oncologie
Santé
Médecine - Divers
Marché du travail
Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development
Source
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Émetteur
Business Wire
1.00
0
10/07/2025
Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development
Source
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Émetteur
Business Wire
1.00
0

Détails du contact

Réseaux sociaux

Followers
0
Compatibilité
0